Tetraiodothyroacetic acid

DB01751ExperimentalSmall molecule

Tetraiodothyroacetic acid: Overview.

Mechanism: Pharmacologically active on Integrin beta-3 and Integrin alpha-V
Curator reviewed
Formula / weight: C₁₄H₈I₄O₄ · 747.8288 g/mol (avg)
Also known as: 3,3',5,5'-tetraiodothyroacetic acid · 3,5-Diiodo-4-(4-hydroxy-3,5-diiodophenoxy)benzeneacetic acid · ACETIC ACID, (4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODOPHENYL)- · T4-ACETIC ACID · Tetrac

Resolves to

Compound

Structure

InChIKeyPPJYSSNKSXAVDB-UHFFFAOYSA-NSMILESOC(=O)CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1

Targets

What you can answer from here — as of September 20, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

9+ReferencesStructured and connected to the statements they support

Which drugs share a target with Tetraiodothyroacetic acid, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.